ProImmune has announced the launch of its ProVE SL Self-Loading MHC Class I Monomers, a new reagent platform designed to enhance antigen-specific CD8+ T cell detection. The Oxford-based life science ...
ProImmune Ltd introduces ProVE® SL Self-Loading MHC Class I Monomers to improve T cell research flexibility ...
Recent analyses show that Omicron variants of SARS-CoV-2 more strongly suppress major histocompatibility complex class I expression than previous versions of the virus. Throughout the pandemic, the ...
The major histocompatibility complex class I (MHC-I) antigen presentation pathway is central to the adaptive immune response. In this process, intracellular proteins are degraded primarily by the ...
Cancer treatments have continuously improved with increasing knowledge about the tumor and the immune system. Starting with surgery and radiation as effective interventions, followed by targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback